Jorge Cabañas-Penagos

Jorge Cabañas-Penagos

Auto-generated profile, based on publicly available information

Jorge Cabañas-Penagos

Andalusian Network of Design and Translation of Advanced Therapies, Unidad de Producción Celular e Ingeniería Tisular, Virgen de las Nieves University Hospital , Granada, 18014

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2024 in Regenerative Biomaterials
Verified
Journal Article
Open access
PDF file
Álvaro Sierra-SánchezÁlvaro Sierra-Sánchez
Álvaro Sierra-Sánchez
JCJorge Cabañas-Penagos
Jorge Cabañas-Penagos
SISandra Igual-Roger
Sandra Igual-Roger
LHLuis Martínez Heredia
Luis Martínez Heredia
OEOlga Espinosa-Ibáñez
Olga Espinosa-Ibáñez
Salvador Arias-SantiagoSalvador Arias-Santiago
Salvador Arias-Santiago
Human plasma is a natural biomaterial that due to their protein composition is widely used for the development of clinical products, especially in the field of dermatology. In this context, this biomaterial has been used as a scaffold alone or combined with others for the development of cellular human plasma-based skin substitutes (HPSSs). Herein, the biological properties (cell viability, cell metabolic activity, protein secretion profile and histology) of several variations of a clinical HPSS model, regarding the biomaterial composition (alone or combined with six secondary biomaterials -serine, fibronectin, collagen, two types of laminins and hyaluronic acid-), the cellular structure (Trilayer, Bilayer, Monolayer and Control without cells) and their skin tissue of origin (abdominal or foreskin cells) and the manufacturing process (effect of partial dehydration process in cell viability and comparison between submerged (SUB) and air/liquid interface (ALI) methodologies) has been evaluated and compared. Results reveal that the use of human plasma as a main biomaterial determines the in vitro properties, rather than the secondary biomaterials added. Moreover, the characteristics are similar regardless of the skin cells used (from abdomen or foreskin). However, the manufacture of more complex cellular substitutes (Trilayer and Bilayer) has been demonstrated to be better in terms of cell viability, metabolic activity and wound healing protein secretion (bFGF, EGF, VEGF-A, CCL5) than Monolayer HPSSs, especially when ALI culture methodology is applied. Moreover, the application of the dehydration, although required to achieve an appropriate clinical structure, reduce cell viability in all cases. These data indicate that this HPSS model is robust and reliable and that the several subtypes here analyzed could be promising clinical approaches depending on the target dermatological disease.